Skip to main content
Top
Published in: Breast Cancer Research 2/2003

01-04-2003 | Viewpoint

New insights into the biological function of BRCA2 from its structural interactions

Author: Alison Waterworth

Published in: Breast Cancer Research | Issue 2/2003

Login to get access

Excerpt

Around 50% of all familial breast and ovarian cancers are due to mutations in BRCA1 and BRCA2. Germline mutations in the BRCA2 gene are associated with an increased susceptibility to breast cancer (in both males and females) and they also confer an increased risk of early onset ovarian, prostate, and pancreatic cancer. The biological function of BRCA2 in the cell is still uncertain, although there is increasing evidence for a role in the repair of DNA by homologous recombination. BRCA2 and RAD51 (a homolog of the baterial recombination protein RecA) both co-localise to nuclear foci thought to be sites of DNA damage and repair and these nuclear foci fail to form in BRCA2 deficient cells. Loss of BRCA2 leads to error prone repair of double strand DNA breaks and in dividing cells can lead to chromosomal abberations and loss of genetic information. Compelling evidence of a more direct role for BRCA2 in DNA repair is provided by two recent studies investigating some of the protein's structural interactions. …
Literature
Metadata
Title
New insights into the biological function of BRCA2 from its structural interactions
Author
Alison Waterworth
Publication date
01-04-2003
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 2/2003
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr581

Other articles of this Issue 2/2003

Breast Cancer Research 2/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine